▶ 調査レポート

世界の結腸直腸がんスクリーニング市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Colorectal Cancer Screening Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の結腸直腸がんスクリーニング市場 2021:企業別、地域別、種類・用途別 / Global Colorectal Cancer Screening Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A12180資料のイメージです。• レポートコード:GIR-107A12180
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、結腸直腸がんスクリーニングのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。結腸直腸がんスクリーニングの種類別市場規模(便検査、結腸内視鏡検査、CTコロノグラフィー、その他)、用途別市場規模(病院、独立診断研究所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・結腸直腸がんスクリーニングの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Abbott、Clinical Genomics Technologies、Epigenomics Inc、Exact Sciences、Roche、Hemosure Inc、Novigenix SA、Quidel、Siemens、Sysmex
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:便検査、結腸内視鏡検査、CTコロノグラフィー、その他
・用途別分析2016年-2026年:病院、独立診断研究所、その他
・結腸直腸がんスクリーニングの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・結腸直腸がんスクリーニングのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・結腸直腸がんスクリーニングのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・結腸直腸がんスクリーニングの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・結腸直腸がんスクリーニングの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Colorectal Cancer Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Colorectal Cancer Screening size is estimated to be USD 728.6 million in 2026 from USD 662.8 million in 2020, with a change XX% between 2020 and 2021. The global Colorectal Cancer Screening market size is expected to grow at a CAGR of 2.4% for the next five years.

Market segmentation
Colorectal Cancer Screening market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Stool-based Tests
Colonoscopy
CT Colonography
Others

Market segment by Application, can be divided into
Hospitals
Independent Diagnostic Labs
Others

Market segment by players, this report covers
Abbott
Clinical Genomics Technologies
Epigenomics Inc
Exact Sciences
Roche
Hemosure Inc
Novigenix SA
Quidel
Siemens
Sysmex

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Colorectal Cancer Screening
1.2 Classification of Colorectal Cancer Screening by Type
1.2.1 Overview: Global Colorectal Cancer Screening Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Colorectal Cancer Screening Revenue Market Share by Type in 2020
1.2.3 Stool-based Tests
1.2.4 Colonoscopy
1.2.5 CT Colonography
1.2.6 Others
1.3 Global Colorectal Cancer Screening Market by Application
1.3.1 Overview: Global Colorectal Cancer Screening Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Independent Diagnostic Labs
1.3.4 Others
1.4 Global Colorectal Cancer Screening Market Size & Forecast
1.5 Global Colorectal Cancer Screening Market Size and Forecast by Region
1.5.1 Global Colorectal Cancer Screening Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Colorectal Cancer Screening Market Size by Region, (2016-2021)
1.5.3 North America Colorectal Cancer Screening Market Size and Prospect (2016-2026)
1.5.4 Europe Colorectal Cancer Screening Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Colorectal Cancer Screening Market Size and Prospect (2016-2026)
1.5.6 South America Colorectal Cancer Screening Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Colorectal Cancer Screening Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Colorectal Cancer Screening Market Drivers
1.6.2 Colorectal Cancer Screening Market Restraints
1.6.3 Colorectal Cancer Screening Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Colorectal Cancer Screening Product and Solutions
2.1.4 Abbott Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Clinical Genomics Technologies
2.2.1 Clinical Genomics Technologies Details
2.2.2 Clinical Genomics Technologies Major Business
2.2.3 Clinical Genomics Technologies Colorectal Cancer Screening Product and Solutions
2.2.4 Clinical Genomics Technologies Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Clinical Genomics Technologies Recent Developments and Future Plans
2.3 Epigenomics Inc
2.3.1 Epigenomics Inc Details
2.3.2 Epigenomics Inc Major Business
2.3.3 Epigenomics Inc Colorectal Cancer Screening Product and Solutions
2.3.4 Epigenomics Inc Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Epigenomics Inc Recent Developments and Future Plans
2.4 Exact Sciences
2.4.1 Exact Sciences Details
2.4.2 Exact Sciences Major Business
2.4.3 Exact Sciences Colorectal Cancer Screening Product and Solutions
2.4.4 Exact Sciences Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Exact Sciences Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Colorectal Cancer Screening Product and Solutions
2.5.4 Roche Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Roche Recent Developments and Future Plans
2.6 Hemosure Inc
2.6.1 Hemosure Inc Details
2.6.2 Hemosure Inc Major Business
2.6.3 Hemosure Inc Colorectal Cancer Screening Product and Solutions
2.6.4 Hemosure Inc Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Hemosure Inc Recent Developments and Future Plans
2.7 Novigenix SA
2.7.1 Novigenix SA Details
2.7.2 Novigenix SA Major Business
2.7.3 Novigenix SA Colorectal Cancer Screening Product and Solutions
2.7.4 Novigenix SA Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novigenix SA Recent Developments and Future Plans
2.8 Quidel
2.8.1 Quidel Details
2.8.2 Quidel Major Business
2.8.3 Quidel Colorectal Cancer Screening Product and Solutions
2.8.4 Quidel Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Quidel Recent Developments and Future Plans
2.9 Siemens
2.9.1 Siemens Details
2.9.2 Siemens Major Business
2.9.3 Siemens Colorectal Cancer Screening Product and Solutions
2.9.4 Siemens Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Siemens Recent Developments and Future Plans
2.10 Sysmex
2.10.1 Sysmex Details
2.10.2 Sysmex Major Business
2.10.3 Sysmex Colorectal Cancer Screening Product and Solutions
2.10.4 Sysmex Colorectal Cancer Screening Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sysmex Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Colorectal Cancer Screening Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Colorectal Cancer Screening Players Market Share
3.2.2 Top 10 Colorectal Cancer Screening Players Market Share
3.2.3 Market Competition Trend
3.3 Colorectal Cancer Screening Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Colorectal Cancer Screening Revenue and Market Share by Type (2016-2021)
4.2 Global Colorectal Cancer Screening Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Colorectal Cancer Screening Revenue Market Share by Application (2016-2021)
5.2 Colorectal Cancer Screening Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Colorectal Cancer Screening Revenue by Type (2016-2026)
6.2 North America Colorectal Cancer Screening Revenue by Application (2016-2026)
6.3 North America Colorectal Cancer Screening Market Size by Country
6.3.1 North America Colorectal Cancer Screening Revenue by Country (2016-2026)
6.3.2 United States Colorectal Cancer Screening Market Size and Forecast (2016-2026)
6.3.3 Canada Colorectal Cancer Screening Market Size and Forecast (2016-2026)
6.3.4 Mexico Colorectal Cancer Screening Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Colorectal Cancer Screening Revenue by Type (2016-2026)
7.2 Europe Colorectal Cancer Screening Revenue by Application (2016-2026)
7.3 Europe Colorectal Cancer Screening Market Size by Country
7.3.1 Europe Colorectal Cancer Screening Revenue by Country (2016-2026)
7.3.2 Germany Colorectal Cancer Screening Market Size and Forecast (2016-2026)
7.3.3 France Colorectal Cancer Screening Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Colorectal Cancer Screening Market Size and Forecast (2016-2026)
7.3.5 Russia Colorectal Cancer Screening Market Size and Forecast (2016-2026)
7.3.6 Italy Colorectal Cancer Screening Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Colorectal Cancer Screening Revenue by Type (2016-2026)
8.2 Asia-Pacific Colorectal Cancer Screening Revenue by Application (2016-2026)
8.3 Asia-Pacific Colorectal Cancer Screening Market Size by Region
8.3.1 Asia-Pacific Colorectal Cancer Screening Revenue by Region (2016-2026)
8.3.2 China Colorectal Cancer Screening Market Size and Forecast (2016-2026)
8.3.3 Japan Colorectal Cancer Screening Market Size and Forecast (2016-2026)
8.3.4 South Korea Colorectal Cancer Screening Market Size and Forecast (2016-2026)
8.3.5 India Colorectal Cancer Screening Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Colorectal Cancer Screening Market Size and Forecast (2016-2026)
8.3.7 Australia Colorectal Cancer Screening Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Colorectal Cancer Screening Revenue by Type (2016-2026)
9.2 South America Colorectal Cancer Screening Revenue by Application (2016-2026)
9.3 South America Colorectal Cancer Screening Market Size by Country
9.3.1 South America Colorectal Cancer Screening Revenue by Country (2016-2026)
9.3.2 Brazil Colorectal Cancer Screening Market Size and Forecast (2016-2026)
9.3.3 Argentina Colorectal Cancer Screening Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Colorectal Cancer Screening Revenue by Type (2016-2026)
10.2 Middle East & Africa Colorectal Cancer Screening Revenue by Application (2016-2026)
10.3 Middle East & Africa Colorectal Cancer Screening Market Size by Country
10.3.1 Middle East & Africa Colorectal Cancer Screening Revenue by Country (2016-2026)
10.3.2 Turkey Colorectal Cancer Screening Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Colorectal Cancer Screening Market Size and Forecast (2016-2026)
10.3.4 UAE Colorectal Cancer Screening Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Colorectal Cancer Screening Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Colorectal Cancer Screening Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Colorectal Cancer Screening Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Colorectal Cancer Screening Revenue (USD Million) by Region (2016-2021)
Table 5. Global Colorectal Cancer Screening Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Colorectal Cancer Screening Product and Solutions
Table 9. Abbott Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Clinical Genomics Technologies Corporate Information, Head Office, and Major Competitors
Table 11. Clinical Genomics Technologies Major Business
Table 12. Clinical Genomics Technologies Colorectal Cancer Screening Product and Solutions
Table 13. Clinical Genomics Technologies Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Epigenomics Inc Corporate Information, Head Office, and Major Competitors
Table 15. Epigenomics Inc Major Business
Table 16. Epigenomics Inc Colorectal Cancer Screening Product and Solutions
Table 17. Epigenomics Inc Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Exact Sciences Corporate Information, Head Office, and Major Competitors
Table 19. Exact Sciences Major Business
Table 20. Exact Sciences Colorectal Cancer Screening Product and Solutions
Table 21. Exact Sciences Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche Colorectal Cancer Screening Product and Solutions
Table 25. Roche Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Hemosure Inc Corporate Information, Head Office, and Major Competitors
Table 27. Hemosure Inc Major Business
Table 28. Hemosure Inc Colorectal Cancer Screening Product and Solutions
Table 29. Hemosure Inc Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novigenix SA Corporate Information, Head Office, and Major Competitors
Table 31. Novigenix SA Major Business
Table 32. Novigenix SA Colorectal Cancer Screening Product and Solutions
Table 33. Novigenix SA Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Quidel Corporate Information, Head Office, and Major Competitors
Table 35. Quidel Major Business
Table 36. Quidel Colorectal Cancer Screening Product and Solutions
Table 37. Quidel Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Siemens Corporate Information, Head Office, and Major Competitors
Table 39. Siemens Major Business
Table 40. Siemens Colorectal Cancer Screening Product and Solutions
Table 41. Siemens Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sysmex Corporate Information, Head Office, and Major Competitors
Table 43. Sysmex Major Business
Table 44. Sysmex Colorectal Cancer Screening Product and Solutions
Table 45. Sysmex Colorectal Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Colorectal Cancer Screening Revenue (USD Million) by Players (2019-2021)
Table 47. Global Colorectal Cancer Screening Revenue Share by Players (2019-2021)
Table 48. Breakdown of Colorectal Cancer Screening by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Colorectal Cancer Screening Players Head Office, Products and Services Provided
Table 50. Colorectal Cancer Screening Mergers & Acquisitions in the Past Five Years
Table 51. Colorectal Cancer Screening New Entrants and Expansion Plans
Table 52. Global Colorectal Cancer Screening Revenue (USD Million) by Type (2016-2021)
Table 53. Global Colorectal Cancer Screening Revenue Share by Type (2016-2021)
Table 54. Global Colorectal Cancer Screening Revenue Forecast by Type (2021-2026)
Table 55. Global Colorectal Cancer Screening Revenue by Application (2016-2021)
Table 56. Global Colorectal Cancer Screening Revenue Forecast by Application (2021-2026)
Table 57. North America Colorectal Cancer Screening Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Colorectal Cancer Screening Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Colorectal Cancer Screening Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Colorectal Cancer Screening Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Colorectal Cancer Screening Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Colorectal Cancer Screening Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Colorectal Cancer Screening Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Colorectal Cancer Screening Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Colorectal Cancer Screening Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Colorectal Cancer Screening Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Colorectal Cancer Screening Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Colorectal Cancer Screening Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Colorectal Cancer Screening Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Colorectal Cancer Screening Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Colorectal Cancer Screening Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Colorectal Cancer Screening Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Colorectal Cancer Screening Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Colorectal Cancer Screening Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Colorectal Cancer Screening Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Colorectal Cancer Screening Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Colorectal Cancer Screening Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Colorectal Cancer Screening Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Colorectal Cancer Screening Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Colorectal Cancer Screening Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Colorectal Cancer Screening Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Colorectal Cancer Screening Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Colorectal Cancer Screening Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Colorectal Cancer Screening Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Colorectal Cancer Screening Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Colorectal Cancer Screening Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Colorectal Cancer Screening Picture
Figure 2. Global Colorectal Cancer Screening Revenue Market Share by Type in 2020
Figure 3. Stool-based Tests
Figure 4. Colonoscopy
Figure 5. CT Colonography
Figure 6. Others
Figure 7. Colorectal Cancer Screening Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Independent Diagnostic Labs Picture
Figure 10. Others Picture
Figure 11. Global Colorectal Cancer Screening Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Colorectal Cancer Screening Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Colorectal Cancer Screening Revenue Market Share by Region (2016-2026)
Figure 14. Global Colorectal Cancer Screening Revenue Market Share by Region in 2020
Figure 15. North America Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Colorectal Cancer Screening Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Colorectal Cancer Screening Market Drivers
Figure 21. Colorectal Cancer Screening Market Restraints
Figure 22. Colorectal Cancer Screening Market Trends
Figure 23. Abbott Recent Developments and Future Plans
Figure 24. Clinical Genomics Technologies Recent Developments and Future Plans
Figure 25. Epigenomics Inc Recent Developments and Future Plans
Figure 26. Exact Sciences Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Hemosure Inc Recent Developments and Future Plans
Figure 29. Novigenix SA Recent Developments and Future Plans
Figure 30. Quidel Recent Developments and Future Plans
Figure 31. Siemens Recent Developments and Future Plans
Figure 32. Sysmex Recent Developments and Future Plans
Figure 33. Global Colorectal Cancer Screening Revenue Share by Players in 2020
Figure 34. Colorectal Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Colorectal Cancer Screening Revenue Market Share in 2020
Figure 36. Global Top 10 Players Colorectal Cancer Screening Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Colorectal Cancer Screening Revenue Share by Type in 2020
Figure 39. Global Colorectal Cancer Screening Market Share Forecast by Type (2021-2026)
Figure 40. Global Colorectal Cancer Screening Revenue Share by Application in 2020
Figure 41. Global Colorectal Cancer Screening Market Share Forecast by Application (2021-2026)
Figure 42. North America Colorectal Cancer Screening Sales Market Share by Type (2016-2026)
Figure 43. North America Colorectal Cancer Screening Sales Market Share by Application (2016-2026)
Figure 44. North America Colorectal Cancer Screening Revenue Market Share by Country (2016-2026)
Figure 45. United States Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Colorectal Cancer Screening Sales Market Share by Type (2016-2026)
Figure 49. Europe Colorectal Cancer Screening Sales Market Share by Application (2016-2026)
Figure 50. Europe Colorectal Cancer Screening Revenue Market Share by Country (2016-2026)
Figure 51. Germany Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Colorectal Cancer Screening Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Colorectal Cancer Screening Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Colorectal Cancer Screening Revenue Market Share by Region (2016-2026)
Figure 59. China Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Colorectal Cancer Screening Sales Market Share by Type (2016-2026)
Figure 66. South America Colorectal Cancer Screening Sales Market Share by Application (2016-2026)
Figure 67. South America Colorectal Cancer Screening Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Colorectal Cancer Screening Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Colorectal Cancer Screening Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Colorectal Cancer Screening Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Colorectal Cancer Screening Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source